betulin has been researched along with lenvatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chen, Z; Fan, M; Li, Y; Lin, J; Lin, Z; Lu, L; Shao, W; Yi, C; Zhou, Y | 1 |
1 other study(ies) available for betulin and lenvatinib
| Article | Year |
|---|---|
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway.
Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Phenylurea Compounds; TOR Serine-Threonine Kinases | 2023 |